[Pharmwaste] (no subject)

Renee Smith rasmith at geisinger.edu
Tue Feb 24 12:11:56 EST 2009

In reading the bill it just mentions "controlled substances." That does not seem to cover all prescription drugs and OTC drugs. Is there more legislation being proposed to cover disposal of all pharmaceuticals by the end user?

Renee Smith

>>> "Sierra Fletcher" <sierra at productstewardship.us> 2/24/2009 9:21 AM >>>
Apologies for cross-postings.


A bill to establish the Safe Drug Disposal Act of 2009 will be
introduced today by Congressman Jay Inslee (D-WA).  The bill seeks to
amend the Controlled Substances Act to allow end users, or care takers
of an end user, to safely dispose of unused prescription drugs and over
the counter drugs through Drug Enforcement Administration (DEA) approved
state run drug take back programs.  Specifically, this bill directs the
DEA to, within one year, create five approved drug take back program
models from which states may choose and implement.  Should a state seek
to implement a different model not listed within those five DEA approved
models, a state must work the DEA to approve the modified version.  

In creating the five specific drug take back program models, the DEA
must comply with a specific set of criteria.  These criteria includes:
1. Protecting the public safety
2. Allowing the ultimate user to dispose of their unused drugs though
persons other than law enforcement
3. Respecting environmentally sound practices for disposal (take back
programs may not include the disposal of drugs through public waterways
or municipal solid waste landfills)
4. Being cost effective for the state
5. Including take back program options for both rural and urban
This bill does not restrict the funding by which a state may use to
implement these programs.


The bill also prohibits pharmaceutical companies from recommending
flushing as a safe means of disposal on prescription drug labels.

Should you have any further questions regarding this legislation, please
feel free to contact Maura Little in Congressman Inslee's office at
202-225-6311 or Maura.Little at gmail.com.

The Product Stewardship Institute will continue to work with our
colleagues from Washington and around the country to discuss and build
support for the bill through our ongoing Regulations Workgroup (part of
the National Dialogue on Waste Pharmaceuticals). If you would like to be
involved, please contact Sierra Fletcher via the phone and email below.



Sierra E. Fletcher

Associate - Policy and Programs

Product Stewardship Institute, Inc.

137 Newbury Street, 7th Floor

Boston, MA 02116

617-236-4886 (phone)

617-859-9889 (fax)

sierra at productstewardship.us 

www.productstewardship.us <http://www.productstewardship.us/> 


IMPORTANT WARNING: The information in this message (and the documents attached to it, if any) is confidential and may be legally privileged. It is intended solely for the addressee. Access to this message by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or any action taken, or omitted to be taken, in reliance on it is prohibited and may be unlawful. If you have received this message in error, please delete all electronic copies of this message (and the documents attached to it, if any), destroy any hard copies you may have created and notify me immediately by replying to this email. Thank you.

More information about the Pharmwaste mailing list